Literature DB >> 18500344

The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers.

Zuyao Ni1, Mohamed Abou El Hassan, Zhaodong Xu, Tao Yu, Rod Bremner.   

Abstract

The chromatin-remodeling enzyme BRG1 is critical for interferon-gamma (IFN-gamma)-mediated gene induction. Promoter-proximal elements are sufficient to mediate BRG1 dependency at some IFN-gamma targets. In contrast, we show here that at CIITA, which encodes the 'master regulator' of induction of major histocompatibility complex class II, distal elements conferred BRG1 dependency. At the uninduced locus, many sites formed BRG1-independent loops. One loop juxtaposed a far downstream element adjacent to a far upstream site. Notably, BRG1 was recruited to the latter site, which triggered the appearance of a histone 'mark' linked to activation. This subtle change was crucial, as subsequent IFN-gamma-induced recruitment of the transcription factors STAT1, IRF1 and p300, as well as histone modifications, accessibility and additional loops, showed BRG1 dependency. Like BRG1, each remote element was critical for the induction of CIITA expression. Thus, BRG1 regulates CIITA through many interdependent remote enhancers, not through the promoter alone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500344     DOI: 10.1038/ni.1619

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  58 in total

1.  NF-κB and BRG1 bind a distal regulatory element in the IL-3/GM-CSF locus.

Authors:  Andrea L Wurster; Patricia Precht; Michael J Pazin
Journal:  Mol Immunol       Date:  2011-08-09       Impact factor: 4.407

2.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 3.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

4.  Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1.

Authors:  Gangqing Hu; Dustin E Schones; Kairong Cui; River Ybarra; Daniel Northrup; Qingsong Tang; Luca Gattinoni; Nicholas P Restifo; Suming Huang; Keji Zhao
Journal:  Genome Res       Date:  2011-07-27       Impact factor: 9.043

5.  SWI/SNF chromatin-remodeling complexes function in noncoding RNA-dependent assembly of nuclear bodies.

Authors:  Tetsuya Kawaguchi; Akie Tanigawa; Takao Naganuma; Yasuyuki Ohkawa; Sylvie Souquere; Gerard Pierron; Tetsuro Hirose
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

Review 6.  The chromatin fingerprint of gene enhancer elements.

Authors:  Gabriel E Zentner; Peter C Scacheri
Journal:  J Biol Chem       Date:  2012-09-05       Impact factor: 5.157

Review 7.  Decoding the non-coding genome: elucidating genetic risk outside the coding genome.

Authors:  C L Barr; V L Misener
Journal:  Genes Brain Behav       Date:  2016-01-04       Impact factor: 3.449

8.  PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA.

Authors:  Hyesuk Yoon; Jeremy M Boss
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

9.  IDO induces expression of a novel tryptophan transporter in mouse and human tumor cells.

Authors:  Jonathan D Silk; Samira Lakhal; Robert Laynes; Laura Vallius; Ioannis Karydis; Cornelius Marcea; C A Richard Boyd; Vincenzo Cerundolo
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

10.  BRG1 directly regulates nucleosome structure and chromatin looping of the alpha globin locus to activate transcription.

Authors:  Shin-Il Kim; Emery H Bresnick; Scott J Bultman
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.